These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3112 related articles for article (PubMed ID: 26269668)

  • 1. Role of the normal gut microbiota.
    Jandhyala SM; Talukdar R; Subramanyam C; Vuyyuru H; Sasikala M; Nageshwar Reddy D
    World J Gastroenterol; 2015 Aug; 21(29):8787-803. PubMed ID: 26269668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbial Changes, Interactions, and Their Implications on Human Lifecycle: An Ageing Perspective.
    Vemuri R; Gundamaraju R; Shastri MD; Shukla SD; Kalpurath K; Ball M; Tristram S; Shankar EM; Ahuja K; Eri R
    Biomed Res Int; 2018; 2018():4178607. PubMed ID: 29682542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E; Monaldi L; Ricci P; Fiorucci S
    World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives.
    Malaguarnera G; Giordano M; Nunnari G; Bertino G; Malaguarnera M
    World J Gastroenterol; 2014 Nov; 20(44):16639-48. PubMed ID: 25469033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity.
    Hwang I; Park YJ; Kim YR; Kim YN; Ka S; Lee HY; Seong JK; Seok YJ; Kim JB
    FASEB J; 2015 Jun; 29(6):2397-411. PubMed ID: 25713030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.
    Matijašić M; Meštrović T; Perić M; Čipčić Paljetak H; Panek M; Vranešić Bender D; Ljubas Kelečić D; Krznarić Ž; Verbanac D
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota in a long survival discourse with the human host.
    Ayariga JA; Ibrahim I; Gildea L; Abugri J; Villafane R
    Arch Microbiol; 2022 Nov; 205(1):5. PubMed ID: 36441284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota.
    Wu M; Wu Y; Deng B; Li J; Cao H; Qu Y; Qian X; Zhong G
    Oncotarget; 2016 Dec; 7(51):85318-85331. PubMed ID: 27863401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of functional food components on gut health.
    Wan MLY; Ling KH; El-Nezami H; Wang MF
    Crit Rev Food Sci Nutr; 2019; 59(12):1927-1936. PubMed ID: 29381385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons.
    Katsi V; Didagelos M; Skevofilax S; Armenis I; Kartalis A; Vlachopoulos C; Karvounis H; Tousoulis D
    Curr Hypertens Rev; 2019; 15(1):40-46. PubMed ID: 29895255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut microbiota composition in dichorionic triplet sets suggests a role for host genetic factors.
    Murphy K; O' Shea CA; Ryan CA; Dempsey EM; O' Toole PW; Stanton C; Ross RP
    PLoS One; 2015; 10(4):e0122561. PubMed ID: 25874766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Importance of the Microbiome in Critically Ill Patients: Role of Nutrition.
    Moron R; Galvez J; Colmenero M; Anderson P; Cabeza J; Rodriguez-Cabezas ME
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants' life: a systematic review.
    Rutayisire E; Huang K; Liu Y; Tao F
    BMC Gastroenterol; 2016 Jul; 16(1):86. PubMed ID: 27475754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic treatments and microbes in the gut.
    Macfarlane S
    Environ Microbiol; 2014 Apr; 16(4):919-24. PubMed ID: 24471523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota and its possible relationship with obesity.
    DiBaise JK; Zhang H; Crowell MD; Krajmalnik-Brown R; Decker GA; Rittmann BE
    Mayo Clin Proc; 2008 Apr; 83(4):460-9. PubMed ID: 18380992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 156.